(R)-2-((4-(((3,4-二氢-2H-吡喃并[2,3-c]吡啶-6-基)甲基)氨基)哌啶-1-基)甲基)-1,2-二氢3H,8H-2a,5,8a-三氮杂苊烯-3,8-二酮

Gepotidacin

产品编号.: A236893 CAS号: 1075236-89-3
分子式: C24H28N6O3 分子量: 448.5175
纯度: 98% MDL NO.:

中文名称:(R)-2-((4-(((3,4-二氢-2H-吡喃并[2,3-c]吡啶-6-基)甲基)氨基)哌啶-1-基)甲基)-1,2-二氢3H,8H-2a,5,8a-三氮杂苊烯-3,8-二酮
CAS号:1075236-89-3
中文别名:(R)-2-((4-(((3,4-二氢-2H-吡喃并[2,3-c]吡啶-6-基)甲基)氨基)哌啶-1-基)甲基)-1,2-二氢3H,8H-2a,5,8a-三氮杂苊烯-3,8-二酮
英文名称:Gepotidacin
英文别名:Gepotidacin;GSK2140944;DVF0PR037D;(2R)-2-[(4-{[(3,4-dihydro-2H-pyrano[2,3-c]pyridin- 6-yl)methyl]amino}piperidin-1-yl)methyl]-1,2-dihydro- 3H,8H-2a,5,8a-triazaacenaphthylene-3,8-dione;Gepotidacin [USAN:INN];GSK 2140944;JHN;Gepotidacin (USAN/INN);GTPL10817;BDBM500505;SCHEMBL3332319;D10878;CS-6531;(3R)-3-[[4-(3,4-dihydro-2H-pyrano[2,3-c]pyridin-6-ylmethylamino)piperidin-1-yl]methyl]-1,4,7-triazatricyclo[6.3.1.04,12]dodeca-6,8(12),9-triene-5,11-dione;DB12134;3H,8H-2a,5,8a-Triazaacenaphthylene-3,8-dione, 2-[[4-[[(3,4-dihydro-2H-pyrano[2,3-c]pyridin-6-yl)methyl]amino]-1-piperidinyl]methyl]-1,2-dihydro-, (2R)-;3H,8H-2a,5,8a-Triazaacenaphthylene-3,8-dione, 2-((4-(((3,4-dihydro-2H-pyrano(2,3-C)pyridin-6-yl)methyl)amino)-1-piperidinyl)methyl)-1,2-dihydro-, (2R)-;DA-73703;Gepotidacin [INN];UNII-DVF0PR037D;1075236-89-3;NS00073409;GEPOTIDACIN [WHO-DD];HY-16742;Q19597285;G14345;(3~{R})-3-[[4-(3,4-dihydro-2~{H}-pyrano[2,3-c]pyridin-6-ylmethylamino)piperidin-1-yl]methyl]-1,4,7-triazatricyclo[6.3.1.0^{4,12}]dodeca-6,8(12),9-triene-5,11-dione;AKOS032946511;GSK 2140944E;GSK-2140944;MS-28128;CHEMBL3317856;BDBM50050549;GEPOTIDACIN [USAN];EX-A7794;DTXSID501028208
EINECS:
分子式:C24H28N6O3
分子量:448.5175
搜索质检报告(COA)
搜索MSDS
已经到最底了
批量搜索 关闭
批处理可以通过CAS号,CAS号,每行一个搜索
...

(R)-2-((4-(((3,4-二氢-2H-吡喃并[2,3-c]吡啶-6-基)甲基)氨基)哌啶-1-基)甲基)-1,2-二氢3H,8H-2a,5,8a-三氮杂苊烯-3,8-二酮
Gepotidacin;GSK2140944;DVF0PR037D;(2R)-2-[(4-{[(3,4-dihydro-2H-pyrano[2,3-c]pyridin- 6-yl)methyl]amino}piperidin-1-yl)methyl]-1,2-dihydro- 3H,8H-2a,5,8a-triazaacenaphthylene-3,8-dione;Gepotidacin [USAN:INN];GSK 2140944;JHN;Gepotidacin (USAN/INN);GTPL10817;BDBM500505;SCHEMBL3332319;D10878;CS-6531;(3R)-3-[[4-(3,4-dihydro-2H-pyrano[2,3-c]pyridin-6-ylmethylamino)piperidin-1-yl]methyl]-1,4,7-triazatricyclo[6.3.1.04,12]dodeca-6,8(12),9-triene-5,11-dione;DB12134;3H,8H-2a,5,8a-Triazaacenaphthylene-3,8-dione, 2-[[4-[[(3,4-dihydro-2H-pyrano[2,3-c]pyridin-6-yl)methyl]amino]-1-piperidinyl]methyl]-1,2-dihydro-, (2R)-;3H,8H-2a,5,8a-Triazaacenaphthylene-3,8-dione, 2-((4-(((3,4-dihydro-2H-pyrano(2,3-C)pyridin-6-yl)methyl)amino)-1-piperidinyl)methyl)-1,2-dihydro-, (2R)-;DA-73703;Gepotidacin [INN];UNII-DVF0PR037D;1075236-89-3;NS00073409;GEPOTIDACIN [WHO-DD];HY-16742;Q19597285;G14345;(3~{R})-3-[[4-(3,4-dihydro-2~{H}-pyrano[2,3-c]pyridin-6-ylmethylamino)piperidin-1-yl]methyl]-1,4,7-triazatricyclo[6.3.1.0^{4,12}]dodeca-6,8(12),9-triene-5,11-dione;AKOS032946511;GSK 2140944E;GSK-2140944;MS-28128;CHEMBL3317856;BDBM50050549;GEPOTIDACIN [USAN];EX-A7794;DTXSID501028208